Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseNCT07446439Vanda PharmaceuticalsPhase 3Recruiting2026-12-01Estimated
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossNCT07446998VERUPhase 2Active not recruiting2027-10Estimated
An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisNCT07449702ORKAPhase 2Recruiting2030-05Estimated
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving BulevirtideNCT07454837MIRMPhase 2, Phase 3Recruiting2027-08-31Estimated
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1NCT07455383Alkermes, Inc.Phase 3Recruiting2027-05Estimated
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)NCT07457918VRCAPhase 3Recruiting2028-04-30Estimated
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCNCT07459634Jazz PharmaceuticalsPhase 2Recruiting2028-01-31Estimated
A Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaNCT07459647MapLight TherapeuticsPhase 2Recruiting2030-02Estimated
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisNCT07459660MapLight TherapeuticsPhase 2Enrolling by invitation2029-03Estimated
A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder CancerNCT07464145RLMDPhase 3Not yet recruiting2029-12Estimated
A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)NCT07465757PBYIPhase 2Recruiting2028-03-31Estimated
Study of Zodasiran in Adolescent Participants With Homozygous Familial HypercholesterolemiaNCT07473843Arrowhead PharmaceuticalsPhase 3Not yet recruiting2028-07Estimated
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisNCT07474792ORKAPhase 2Recruiting2027-10Estimated
Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin LymphomaNCT07477366IBRXPhase 2Not yet recruiting2027-12Estimated
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder CancerNCT07480356Protara TherapeuticsPhase 3Recruiting2028-04Estimated
Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett SyndromeNCT07480564TSHAPhase 3Active not recruiting2031-06Estimated
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial VirusNCT07482657ENTAPhase 2Recruiting2026-12Estimated
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolNCT07484217AXSMPhase 3Recruiting2028-12Estimated
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1NCT07486934Dyne TherapeuticsPhase 3Recruiting2028-07Estimated
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaNCT07491445RVMDPhase 3Recruiting2028-06Estimated
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric ParticipantsNCT07494045OPKPhase 2Recruiting2027-10Estimated
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.NCT07494305LBRXPhase 2Recruiting2028-02Estimated
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07495852Glaukos CorporationPhase 3Recruiting2028-06Estimated
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2NCT07502443Alkermes, Inc.Phase 3Recruiting2027-05Estimated
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic TargetsNCT07502495BMEAPhase 2Active not recruiting2027-03Estimated
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapyNCT07502508BMEAPhase 2Recruiting2027-06Estimated
Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelNCT07503405TRAWPhase 2Not yet recruiting2026-11Estimated
A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)NCT07503873TGTXPhase 2Recruiting2027-07-31Estimated
Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresNCT07505004Praxis Precision MedicinesPhase 3Active not recruiting2027-01Estimated
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)NCT07506863AGIOPhase 3Recruiting2029-06Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.